A Phase I/II, Placebo-controlled, Randomized, Double-blind, dose-finding Study to Evaluate the Safety, Tolerability, and Immunogenicity of AdimrSC-2f Vaccine in Healthy Adults
Penulis/Author
Tanggal/Date
2022
Abstrak/Abstract
This study is phase I/II, Placebo-controlled, Randomized, Double-blind, dose-finding Study to Evaluate the Safety, Tolerability, and Immunogenicity of AdimrSC-2f Vaccine in Healthy Adults. It is conducted in UGM Academic Hospital from March, 2021 until now.
